We are live on ! Find out more
WIC

Whitegate Investment Counselors Portfolio holdings

AUM $315M
1-Year Est. Return 10.6%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+10.6%
3 Year Est. Return
+40.31%
5 Year Est. Return
+41.03%
10 Year Est. Return
+196.73%
AUM
$497M
AUM Growth
+$14.4M
Cap. Flow
+$707M
Cap. Flow %
142.08%
Top 10 Hldgs %
26.62%
Holding
204
New
6
Increased
68
Reduced
84
Closed
6

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$953K
2
MMM icon
3M
MMM
+$830K
3
DIS icon
Walt Disney
DIS
+$354K
4
WBA
Walgreens Boots Alliance
WBA
+$305K
5
NWL icon
Newell Brands
NWL
+$259K

Sector Composition

Rank Sector Weight
1 Financials 11.53%
2 Technology 9.65%
3 Healthcare 9.54%
4 Industrials 5.86%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
176
Sysco
SYY
$40.3B
$233K 0.05%
3,300
IJS icon
177
iShares S&P Small-Cap 600 Value ETF
IJS
$8.37B
$232K 0.05%
3,126
+50
+2% +$3.71K
IEFA icon
178
iShares Core MSCI EAFE ETF
IEFA
$196B
$231K 0.05%
3,764
+149
+4% +$9.13K
WPC icon
179
W.P. Carey
WPC
$16.4B
$229K 0.05%
2,884
IBDK
180
DELISTED
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
$224K 0.05%
9,000
KHC icon
181
Kraft Heinz
KHC
$30B
$220K 0.04%
7,084
-3,200
-31% -$101K
KRE icon
182
State Street SPDR S&P Regional Banking ETF
KRE
$4.57B
$218K 0.04%
4,075
LLY icon
183
Eli Lilly
LLY
$1.06T
$207K 0.04%
1,867
BWA icon
184
BorgWarner
BWA
$13.9B
$205K 0.04%
5,561
-1,408
-20% -$49.9K
CBRE icon
185
CBRE Group
CBRE
$42.9B
$205K 0.04%
+4,000
New +$199K
MBRX icon
186
Moleculin Biotech
MBRX
$2.91M
$190K 0.04%
67
ICAD
187
DELISTED
iCAD Inc
ICAD
$69K 0.01%
10,907
OGI
188
Organigram Holdings
OGI
$139M
$64K 0.01%
+2,500
New +$69.4K
ORN icon
189
Orion Group Holdings
ORN
$418M
$57K 0.01%
21,100
CPRX
190
DELISTED
Catalyst Pharmaceutical
CPRX
$38K 0.01%
10,000
CTLP
191
DELISTED
Cantaloupe
CTLP
-10,000
Closed -$42K
DD icon
192
DuPont de Nemours
DD
$19.2B
-1,498
Closed -$202K
WBA
193
DELISTED
Walgreens Boots Alliance
WBA
-4,820
Closed -$305K
XLI icon
194
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
-2,675
Closed -$201K
MBII
195
DELISTED
Marrone Bio Innovations, Inc.
MBII
-15,000
Closed -$23K

Similar funds

Whitegate Investment Counselors's Q2 2019 Portfolio in Review

As of Q2 2019, Whitegate Investment Counselors held 204 positions worth $497M, up 3% from $483M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Whitegate Investment Counselors deployed $707M of net new capital in Q2 2019, opening 6 new positions and adding to 68 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 2,300 shares worth $7.32M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 9.5% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Novartis, an estimated $953K trimmed.

  • Whitegate Investment Counselors's largest Q2 2019 buy was Berkshire Hathaway Class A: 2,300 shares worth $7.32M.
  • Whitegate Investment Counselors added most to WisdomTree US MidCap Dividend Fund in Q2 2019, an estimated $487K increase.
  • Whitegate Investment Counselors's biggest Q2 2019 reduction was Novartis, cutting an estimated $953K.
  • Whitegate Investment Counselors fully exited Walgreens Boots Alliance in Q2 2019, selling an estimated $305K.
  • Whitegate Investment Counselors's ten largest holdings make up 27% of its $497M portfolio in Q2 2019.
  • Whitegate Investment Counselors opened 6 new positions and closed 6 in Q2 2019.
  • Whitegate Investment Counselors's portfolio value rose 3% quarter-over-quarter to $497M.

Based on Whitegate Investment Counselors's 13F filing for Q2 2019, filed 26 Jul 2019.